切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2025, Vol. 14 ›› Issue (02) : 262 -269. doi: 10.3877/cma.j.issn.2095-3232.2025038

临床研究

ERCP 联合SpyGlass 内镜下射频消融+光动力疗法+胆道支架置入综合治疗在晚期胆管癌中的应用
韩沁颖1,2, 高磊1,2, 何普毅1,2, 王云鹏1,2, 王转芳1,2, 何丽娟1,2, 刘犇1,2, 许博1,2, 胡继科1,2, 蒲唯高1,2, 陈昊1,3,2,()   
  1. 1. 730030 兰州大学第二临床医学院
    2. 730030 兰州,甘肃省环境肿瘤学重点实验室
    3. 730030 兰州大学第二医院肿瘤外科
  • 收稿日期:2024-11-18 出版日期:2025-04-10
  • 通信作者: 陈昊
  • 基金资助:
    国家自然科学基金面上项目(82473266)甘肃省卫生健康行业科技创新重大科研项目(GSWSZD-2024-17)甘肃省科技重大专项(22ZD6FA054)兰州大学医学教育创新发展项目-医学科研创新能力提升项目(lzuyxcx-2022-160)兰州大学医学教育创新发展项目-精品教材培育项目(lzuyxcx-2022-45)“萃英科技创新”计划项目(CY2023-ZD-01)

Application of ERCP combined with SpyGlass endoscopic radiofrequency ablation+photodynamic therapy+biliary stenting in advanced cholangiocarcinoma

Qinying Han1,2, Lei Gao1,2, Puyi He1,2, Yunpeng Wang1,2, Zhuanfang Wang1,2, Lijuan He1,2, Ben Liu1,2, Bo Xu1,2, Jike Hu1,2, Weigao Pu1,2, Hao Chen1,3,2,()   

  1. 1. The Second Clinical Medical School of Lanzhou University,Lanzhou 730030,China
    2. Gansu Provincial Key Laboratory of Environmental Oncology,Lanzhou 730030,China
    3. Department of Surgical Oncology,the Second Hospital of Lanzhou University,Lanzhou 730030,China
  • Received:2024-11-18 Published:2025-04-10
  • Corresponding author: Hao Chen
引用本文:

韩沁颖, 高磊, 何普毅, 王云鹏, 王转芳, 何丽娟, 刘犇, 许博, 胡继科, 蒲唯高, 陈昊. ERCP 联合SpyGlass 内镜下射频消融+光动力疗法+胆道支架置入综合治疗在晚期胆管癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 262-269.

Qinying Han, Lei Gao, Puyi He, Yunpeng Wang, Zhuanfang Wang, Lijuan He, Ben Liu, Bo Xu, Jike Hu, Weigao Pu, Hao Chen. Application of ERCP combined with SpyGlass endoscopic radiofrequency ablation+photodynamic therapy+biliary stenting in advanced cholangiocarcinoma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2025, 14(02): 262-269.

目的

探讨ERCP 联合SpyGlass 内镜下射频消融(RFA)+光动力疗法(PDT)+胆道支架置入(BS)综合治疗在晚期胆管癌中的应用价值。

方法

回顾性分析2023 年 6 月兰州大学第二医院收治的1 例胆管癌患者临床资料。患者女,61 岁,主因“进食后上腹胀痛1 月”于2023 年6 月13 日收入院。查体:皮肤黏膜及巩膜轻度黄染,中上腹及脐周可触及包块,质硬,可活动;左锁骨上肿物,约2 cm×1 cm,无红肿、疼痛、破溃。肿瘤标记物:CA19-9>1 000 kU/L,CEA 251 μg/L,CA72-4 32.8 kU/L。CT 示胆总管上段管壁稍增厚并明显强化,MRCP 示肝总管与胆总管交界处胆管管壁环形增厚呈软组织影,考虑胆管癌。初步诊断胆管癌并颈部淋巴结转移。

结果

积极术前准备后行ERCP 内镜SpyGlass下黏膜活检,示胆管印戒细胞癌。内镜下置入1 胆道金属裸支架(0.6 cm×1.0 cm),联合RFA 及PDT综合治疗,PDT 治疗1 次/d,共治疗3 d。术后辅助白蛋白紫杉醇+卡培他滨系统治疗。经治疗后肝功能指标明显好转,CEA 经治疗后复查降为169 μg/L。复查MRCP 示肝总管与胆总管交界处胆管管壁环形增厚程度较前减轻,相应管腔狭窄程度及肝内胆管扩张程度较前减轻。

结论

ERCP 下BS 联合RFA及PDT 为晚期胆管癌患者的内镜综合治疗提供了新的思路,使更多晚期胆管癌患者获益。

Objective

To evaluate the application value of ERCP combined with SpyGlass endoscopic radiofrequency ablation (RFA)+ photodynamic therapy (PDT)+ biliary stenting (BS) in advanced cholangiocarcinoma.

Methods

Clinical data of 1 patient with cholangiocarcinoma admitted to the Second Hospital of Lanzhou University in June 2023 were analyzed retrospectively.On June 13,2023, the 61-year-old female patient was admitted to the hospital due to “abdominal pain after eating for 1 month”.Physical examination: the skin mucosa and sclera were slightly yellow, and a firm and movable mass was palpable in the middle and upper abdomen and around the umbilicus.The left supraclavicular mass was approximately 2 cm×1 cm, without redness, swelling, pain and ulceration.Tumor markers:CA19-9>1 000 kU/L, CEA 251 μg/L and CA72-4 32.8 kU/L.CT scan showed that the wall of the upper segment of common bile duct was slightly thickened and significantly enhanced.MRCP revealed that the circular thickening of the wall of common bile duct at the junction of the common hepatic duct and common bile duct, manifested as soft tissue shadow, which was considered as cholangiocarcinoma.Preliminary diagnosis of cholangiocarcinoma complicated with cervical lymph node metastasis was made.

Results

After comprehensive preoperative preparation, ERCP combined with SpyGlass endoscopic mucosal biopsy revealed signet ring cell carcinoma of the bile duct.A bare metal biliary stent (0.6 cm×1.0 cm) was implanted under endoscope combined with RFA and PDT.PDT was given once a day for 3 d.Postoperative adjuvant systemic therapy of albumin paclitaxel+capecitabine was delivered.After corresponding treatment, liver function indexes were significantly improved.CEA level was significantly declined from 251 μg/L to 169 μg/L.Repeated MRCP showed that the annular thickening of bile duct wall at the junction of the common bile duct and common bile duct was mitigated, and corresponding lumen stenosis and intrahepatic bile duct dilatation were also alleviated.

Conclusions

BS combined with RFA and PDT under ERCP provides a novel idea for comprehensive endoscopic treatment for patients with advanced cholangiocarcinoma, which will bring more benefits.

图1 一例晚期胆管癌患者活检组织免疫组化法染色(×400) 注:a、b、c、分别为Ki-67、MUC2、Syn(+)
图2 一例晚期胆管癌患者ERCP 联合SpyGlass 下行RFA+胆管支架置入术中情况 注:a 示切开十二指肠乳头并行柱状球囊扩张,b 示RFA,c 示放置胆道支架;RFA 为射频消融
图3 一例晚期胆管癌患者ERCP 联合SpyGlass 下行综合治疗前后MRCP 检查图 注:a 为治疗前见胆道梗阻,b 为治疗后见胆道梗阻情况缓解
[1]
Ilyas SI, Khan SA, Hallemeier CL, et al.Cholangiocarcinomaevolving concepts and therapeutic strategies[J].Nat Rev Clin Oncol,2018, 15(2): 95-111.DOI: 10.1038/nrclinonc.2017.157.
[2]
Witzigmann H, Berr F, Ringel U, et al.Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma:palliative photodynamic therapy plus stenting is comparable to r1/r2 resection[J].Ann Surg, 2006, 244(2): 230-239.DOI: 10.1097/01.sla.0000217639.10331.47.
[3]
李佳隆, 邵英梅.肝门部胆管癌外科治疗的现状与展望[J].中国普外基础与临床杂志, 2022, 29(11): 1528-1533.DOI: 10.7507/1007-9424.202205016.Li JL, Shao YM.Current situation and prospect of surgical treatment of hilar cholangiocarcinoma[J].Chin J Bases Clin Gen Surg, 2022,29(11): 1528-1533.DOI: 10.7507/1007-9424.202205016.
[4]
陆知非, 王高卿, 高过.肝门部胆管癌的非手术治疗进展[J].临床荟萃, 2023, 38(5): 473-476.DOI: 10.3969/j.issn.1004-583X.2023.05.017.Lu ZF, Wang GQ, Gao G.Progress in non-surgical treatment of anal cholangiocarcinoma[J].Clin Focus, 2023, 38(5): 473-476.DOI: 10.3969/j.issn.1004-583X.2023.05.017.
[5]
高道键, 胡冰.内镜下射频消融术治疗恶性胆道狭窄研究进展[J].中国实用外科杂志, 2017, 37(8): 925-928.DOI: 10.19538/j.cjps.issn 1005-2208.2017.08.25.Gao DJ, Hu B.Research progress of endoscopic radiofrequency ablation in the treatment of malignant biliary stricture[J].Chin J Pract Surg, 2017, 37(8): 925-928.DOI: 10.19538/j.cjps.issn1005-2208.2017.08.25.
[6]
Li X, Lovell JF, Yoon J, et al.Clinical development and potential of photothermal and photodynamic therapies for cancer[J].Nat Rev Clin Oncol, 2020, 17(11): 657-674.DOI: 10.1038/s41571-020-0410-2.
[7]
卢心毓, 王林恒, 江贵, 等.内镜逆行胰胆管造影联合SpyGlass确诊胆囊黏液腺瘤1例报告[J].临床肝胆病杂志, 2023, 39(5): 1162-1165.Lu XY, Wang LH, Jiang G, et al.Mucinous gallbladder adenoma diagnosed by endoscopic retrograde cholangiopancreatography and SpyGlass: a case report[J].J Clin Hepatol, 2023, 39(5): 1162-1165.
[8]
田青, 张雅敏.胆管癌内镜治疗的研究进展[J].中国城乡企业卫生,2017, 32(6): 27-30.DOI: 10.16286/j.1003-5052.2017.06.011.Tian Q, Zhang YM.Research progress in endoscopic treatment of cholangiocarcinoma[J].Chin J Urban Rural Enterp Hyg, 2017, 32(6):27-30.DOI: 10.16286/j.1003-5052.2017.06.011.
[9]
Renzulli M, Ramai D, Singh J, et al.Locoregional treatments in cholangiocarcinoma and combined hepatocellular cholangiocarcinoma[J].Cancers, 2021, 13(13): 3336.DOI: 10.3390/cancers13133336.
[10]
盛宇斌, 梁霄.腹腔镜手术治疗肝内胆管细胞癌研究现状[J].中国实用外科杂志, 2022, 42(7): 833-835.DOI: 10.19538/j.cjps.issn1005-2208.2022.07.28.Sheng YB, Liang X.Current situation and future prospect of laparoscopic treatment of intrahepatic cholangiocarcinoma[J].Chin J Pract Surg, 2022, 42(7): 833-835.DOI: 10.19538/j.cjps.issn1005-2208.2022.07.28.
[11]
王荇, 李相成.胆管癌姑息治疗的研究进展[J].临床肝胆病杂志,2016, 32(5): 1022-1025.DOI: 10.3969/j.issn.1001-5256.2016.05.051.Wang X, Li XC.Research advances in palliative treatment of cholangiocarcinoma[J].J Clin Hepatol, 2016, 32(5): 1022-1025.DOI:10.3969/j.issn.1001-5256.2016.05.051.
[12]
Blechacz B, Gores GJ.Cholangiocarcinoma: advances in pathogenesis,diagnosis, and treatment[J].Hepatology, 2008, 48(1): 308-321.DOI:10.1002/hep.22310.
[13]
马升明, 刘建文, 郭艳, 等.肝门胆管癌不同手术方案治疗的临床效果及预后影响因素分析[J].实用癌症杂志, 2023, 38(7): 1194-1196.DOI: 10.3969/j.issn.1001-5930.2023.07.041.Ma SM, Liu JW, Guo Y, et al.Clinical effect of different surgical methods for hepatic portal cholangiocarcinoma and prognostic factors[J].Pract J Cancer, 2023, 38(7): 1194-1196.DOI: 10.3969/j.issn.1001-5930.2023.07.041.
[14]
傅奎, 龚建平, 熊彬.ERCP在胆管癌诊断和治疗中的研究进展[J].现代医药卫生, 2020, 36(22): 3597-3600.DOI: 10.3969/j.issn.1009-5519.2020.22.018.Fu K, Gong JP, Xiong B.Research progress of ERCP in diagnosis and treatment of cholangiocarcinoma[J].J Mod Med Health, 2020, 36(22):3597-3600.DOI: 10.3969/j.issn.1009-5519.2020.22.018.
[15]
李祥玉, 仲恒高, 王芸, 等.十二指肠镜下经乳头胆管腔内球囊扩张联合胆管活检对肝外胆管狭窄的诊治价值[J].河北医药, 2020,42(7): 998-1002.DOI: 10.3969/j.issn.1002-7386.2020.07.008.Li XY, Zhong HG, Wang Y, et al.The application value of balloon dilatation combined with biopsy forceps under the endoscopic retrograde cholangiogancretography in diagnosis of extrahepatic bile duct stricture[J].Hebei Med J, 2020, 42(7): 998-1002.DOI: 10.3969/j.issn.1002-7386.2020.07.008.
[16]
Chen WM, Wei KL, Chen YS, et al.Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer[J].World J Surg Oncol, 2016, 14: 140.DOI:10.1186/s12957-016-0883-8.
[17]
王毅兰, 李喆楠, 王军民.SpyGlass在胆胰疾病诊治中的研究进展[J].河北医科大学学报, 2023, 44(2): 241-245.DOI: 10.3969/j.issn.1007-3205.2023.02.023.Wang YL, Li ZN, Wang JM.Research progress of SpyGlass in diagnosis and treatment of biliary and pancreatic diseases[J].J Hebei Med Univ, 2023, 44(2): 241-245.DOI: 10.3969/j.issn.1007-3205.2023.02.023.
[18]
Sofi AA, Khan MA, Das A, et al.Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis[J].Gastrointest Endosc, 2018, 87(4): 944-951.e1.DOI: 10.1016/j.gie.2017.10.029.
[19]
Mensah ET, Martin J, Topazian M.Radiofrequency ablation for biliary malignancies[J].Curr Opin Gastroenterol, 2016, 32(3): 238-243.DOI:10.1097/MOG.0000000000000258.
[20]
Bokemeyer A, Gross D, Brückner M, et al.Digital single-operator cholangioscopy: a useful tool for selective guidewire placements across complex biliary strictures[J].Surg Endosc, 2019, 33(3): 731-737.DOI: 10.1007/s00464-018-6334-6.
[21]
赵鹏程.恶性梗阻性黄疸及其引流方式对腹腔镜胰十二指肠切除术后并发症的影响分析[D].长春: 吉林大学, 2022.DOI: 10.27162/d.cnki.gjlin.2022.005388.Zhao PC.Analysis of the influence of malignant obstructive jaundice and its drainage mode on complications after laparoscopic pancreaticoduodenectomy [D].Changchun: Jilin University, 2022.DOI: 10.27162/d.cnki.gjlin.2022.005388.
[22]
郭志唐, 白锦峰, 孙敏, 等.PTCD与ERCP+ENBD在恶性梗阻性黄疸姑息性治疗中疗效比较[J/OL].中华肝脏外科手术学电子杂志, 2021, 10(6): 564-569.DOI: 10.3877/cma.j.issn.2095-3232.2021.06.007.Guo ZT, Bai JF, Sun M, et al.Comparison of efficacy between PTCD and ERCP+ENBD in palliative treatment of malignant obstructive jaundice[J/OL].Chin J Hepatic Surg (Electronic Edition), 2021, 10(6):564-569.DOI: 10.3877/cma.j.issn.2095-3232.2021.06.007
[23]
Kwiatkowski S, Knap B, Przystupski D, et al.Photodynamic therapy-mechanisms, photosensitizers and combinations[J].Biomed Pharmacother, 2018, 106: 1098-1107.DOI: 10.1016/j.biopha.2018.07.049.
[24]
Moole H, Tathireddy H, Dharmapuri S, et al.Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma:a systematic review and meta-analysis[J].World J Gastroenterol, 2017,23(7): 1278-1288.DOI: 10.3748/wjg.v23.i7.1278.
[25]
Hendriquez R, Keihanian T, Goyal J, et al.Radiofrequency ablation in the management of primary hepatic and biliary tumors[J].World J Gastrointest Oncol, 2022, 14(1): 203-215.DOI: 10.4251/wjgo.v14.i1.203.
[26]
Mizukoshi E, Yamashita T, Arai K, et al.Enhancement of tumorassociated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma[J].Hepatology, 2013, 57(4): 1448-1457.DOI: 10.1002/hep.26153.
[27]
de Jong DM, Fritzsche JA, Audhoe AS, et al.Comparison of intraductal RFA plus stent versus stent-only treatment for unresectable perihilar cholangiocarcinoma:a systematic review and meta-analysis[J].Cancers, 2022, 14(9): 2079.DOI: 10.3390/cancers14092079.
[28]
Buerlein RCD, Wang AY.Endoscopic retrograde cholangiopancreatography-guided ablation for cholangiocarcinoma[J].Gastrointest Endosc Clin N Am, 2019, 29(2): 351-367.DOI: 10.1016/j.giec.2018.11.006.
[29]
Inoue T, Yoneda M.Updated evidence on the clinical impact of endoscopic radiofrequency ablation in the treatment of malignant biliary obstruction[J].Dig Endosc, 2022, 34(2): 345-358.DOI:10.1111/den.14059.
[30]
Cho JH, Jeong S, Kim EJ, et al.Long-term results of temperaturecontrolled endobiliary radiofrequency ablation in a normal swine model[J].Gastrointest Endosc, 2018, 87(4): 1147-1150.DOI: 10.1016/j.gie.2017.09.013.
[31]
周鸿鲲, 秦运升, 张杰, 等.胆道金属支架联合腔内射频消融治疗恶性胆道梗阻28例分析[J].肿瘤学杂志, 2021, 27(12): 1050-1053.DOI: 10.11735/j.issn.1671-170X.2021.12.B014.Zhou HK, Qin YS, Zhang J, et al.An analysis of biliary stent combined with intraluminal radiofrequency ablation for 28 cases with malignant biliary obstruction[J].J Chin Oncol, 2021, 27(12): 1050-1053.DOI: 10.11735/j.issn.1671-170X.2021.12.B014.
[32]
Ortner MEJ, Caca K, Berr F, et al.Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study[J].Gastroenterology, 2003, 125(5): 1355-1363.DOI: 10.1016/j.gastro.2003.07.015.
[33]
卫怡蓉.内镜下射频消融或光动力治疗联合金属支架植入对不可切除的肝外胆管癌的疗效分析[D].太原: 山西医科大学, 2021.DOI: 10.27288/d.cnki.gsxyu.2021.000493.Wei YR.Endoscopic radiofrequency ablation or photodynamic therapy combined with metal stent implantation for unresectable extrahepatic cholangiocarcinoma[D].Taiyuan: Shanxi Medical University, 2021.DOI: 10.27288/d.cnki.gsxyu.2021.000493.
[34]
郭子倩, 牛立志, 邓春娟, 等.内镜下射频消融联合光动力学疗法治疗无法手术切除的梗阻性肺癌——附34例报告[J].中国激光医学杂志, 2006, 15(2): 102-106.DOI: 10.13480/j.issn1003-9430.2006.02.010.Guo ZQ, Niu LZ, Deng CJ, et al.Endoscopic laser therapy treating thirty-four patients with inoperable malignant obstructive lung cancer using sequential photodynamic therapy and radiofrequency[J].Chin J Laser Med Surg, 2006, 15(2): 102-106.DOI: 10.13480/j.issn1003-9430.2006.02.010.
[35]
江德灿.小切开联合EPBD扩张时间对ERCP术后并发症的临床研究[D].广州: 广州医科大学, 2018.DOI: 10.7666/d.D01553326.Jiang DC.Clinical study of small incision combined with EPBD expansion time on postoperative complications of ERCP[D].Guangzhou: Guangzhou Medical University, 2018.DOI: 10.7666/d.D01553326.
[36]
Wang AY, Yachimski PS.Endoscopic management of pancreatobiliary neoplasms[J].Gastroenterology, 2018, 154(7): 1947-1963.DOI:10.1053/j.gastro.2017.11.295.
[1] 聂生军, 王钰, 王毅, 鲜小庆, 马生成. 复方倍他米松局部注射联合光动力疗法治疗小型瘢痕疙瘩的临床疗效观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 404-410.
[2] 徐楠, 杨云川, 周迟, 马翔, 鲁正, 崔培元. 脾动脉结扎在肝门胆管癌行大范围肝切除中的临床作用研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 271-274.
[3] 董家旭, 宋美姿, 毕讯. 射频消融术联合TSH抑制治疗甲状腺微小乳头状癌的效果及生存预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 200-203.
[4] 杨建波, 马欢, 黄小梅, 刘华柱. 结肠镜辅助下EMR、CSP和RFA术治疗直径<1cm结直肠息肉的疗效和安全性比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 76-79.
[5] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[6] 臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[7] 方开萱, 翟亚奇, 张贯军, 陈升鑫, 陈德鑫, 刘文静, 梁雅文, 李明阳. 内镜逆行胰胆管造影术治疗胰腺分裂症的安全性与远期疗效[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 284-289.
[8] 董思帆, 安仕琪, 刘起帆, 王楚风, 蒋安. 光动力疗法在晚期胆管癌姑息性治疗中的安全性和疗效Meta 分析[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 68-73.
[9] 孙志鹏, 束斌, 王良, 黄鑫, 王鹏飞, 李广欣, 王小娟, 黎功, 杨世忠. 放疗联合靶向免疫新辅助治疗肝内胆管细胞癌的安全性与疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 92-96.
[10] 邱枫, 杨天池, 韩威. 腹腔镜超声引导下射频消融治疗肝脏恶性肿瘤的安全性与疗效分析[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 102-106.
[11] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[12] 王春莹, 江永强, 韩海静, 苏红霞, 李转, 党飞, 折彤, 屈耀宁. 血清SAA、sIL-2R水平与内镜逆行胰胆管造影术后胰腺炎严重程度的相关性及预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(01): 46-50.
[13] 莫鹏, 郭杏春, 梁秀娟, 王耀明. 超声引导与CT引导射频消融治疗肝细胞癌患者疗效及预后比较[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(02): 151-154.
[14] 陈轶维, 吴近近, 李奋, 孙彦隽, 郁夏风. 儿童左心耳起源房性心动过速镶嵌治疗一例[J/OL]. 中华心脏与心律电子杂志, 2024, 12(03): 185-188.
[15] 王楠钧, 马燕, 李隆松, 牛晓彤, 刘圣圳, 毕雅维, 苏松, 柴宁莉, 令狐恩强. 不同年龄段胃低级别上皮内瘤变患者内镜下射频消融术的疗效对比分析[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(04): 238-242.
阅读次数
全文


摘要